1. Home
  2. CNTX vs CSTE Comparison

CNTX vs CSTE Comparison

Compare CNTX & CSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • CSTE
  • Stock Information
  • Founded
  • CNTX 2015
  • CSTE 1987
  • Country
  • CNTX United States
  • CSTE Israel
  • Employees
  • CNTX N/A
  • CSTE N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • CSTE Building Materials
  • Sector
  • CNTX Health Care
  • CSTE Industrials
  • Exchange
  • CNTX Nasdaq
  • CSTE Nasdaq
  • Market Cap
  • CNTX 75.6M
  • CSTE 61.9M
  • IPO Year
  • CNTX 2021
  • CSTE 2012
  • Fundamental
  • Price
  • CNTX $1.26
  • CSTE $1.26
  • Analyst Decision
  • CNTX Strong Buy
  • CSTE
  • Analyst Count
  • CNTX 7
  • CSTE 0
  • Target Price
  • CNTX $5.20
  • CSTE N/A
  • AVG Volume (30 Days)
  • CNTX 500.2K
  • CSTE 73.3K
  • Earning Date
  • CNTX 11-10-2025
  • CSTE 11-12-2025
  • Dividend Yield
  • CNTX N/A
  • CSTE N/A
  • EPS Growth
  • CNTX N/A
  • CSTE N/A
  • EPS
  • CNTX N/A
  • CSTE N/A
  • Revenue
  • CNTX N/A
  • CSTE $406,178,000.00
  • Revenue This Year
  • CNTX N/A
  • CSTE N/A
  • Revenue Next Year
  • CNTX N/A
  • CSTE $5.61
  • P/E Ratio
  • CNTX N/A
  • CSTE N/A
  • Revenue Growth
  • CNTX N/A
  • CSTE N/A
  • 52 Week Low
  • CNTX $0.49
  • CSTE $1.20
  • 52 Week High
  • CNTX $2.46
  • CSTE $5.04
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 56.22
  • CSTE 33.30
  • Support Level
  • CNTX $1.19
  • CSTE $1.51
  • Resistance Level
  • CNTX $1.50
  • CSTE $1.48
  • Average True Range (ATR)
  • CNTX 0.15
  • CSTE 0.11
  • MACD
  • CNTX -0.02
  • CSTE -0.03
  • Stochastic Oscillator
  • CNTX 39.78
  • CSTE 14.93

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

Share on Social Networks: